Although further studies are needed to understand the interaction between LPCAT1 and the PAF/PAFR pathway and its functions in the cancer microenvironment, LPCAT1 is a potential biomarker of aggressive tumoral progression in human primary OSCCs. The gene discussed is LPCAT1; the disease is cancer.